Nishijima H - Search Results

1

Clinical availability of skin biopsy in the diagnosis of Parkinson's disease.

Miki Y, Tomiyama M, Ueno T, Haga R, Nishijima H, Suzuki C, Mori F, Kaimori M, Baba M, Wakabayashi K. Miki Y, et al. Among authors: nishijima h. Neurosci Lett. 2010 Jan 29;469(3):357-9. doi: 10.1016/j.neulet.2009.12.027. Epub 2009 Dec 18. Neurosci Lett. 2010. PMID: 20026177

2

Clinical Utility of Skin Biopsy in Differentiating between Parkinson's Disease and Multiple System Atrophy.

Haga R, Sugimoto K, Nishijima H, Miki Y, Suzuki C, Wakabayashi K, Baba M, Yagihashi S, Tomiyama M. Haga R, et al. Among authors: nishijima h. Parkinsons Dis. 2015;2015:167038. doi: 10.1155/2015/167038. Epub 2015 Apr 6. Parkinsons Dis. 2015. PMID: 25945280 Free PMC article.

3

Levodopa-induced morphologic changes of prefrontal pyramidal tract-type neurons in a rat model of Parkinson's disease.

Nishijima H, Ueno T, Ueno S, Mori F, Miki Y, Tomiyama M. Nishijima H, et al. Neurosci Res. 2017 Feb;115:54-58. doi: 10.1016/j.neures.2016.10.001. Epub 2016 Oct 20. Neurosci Res. 2017. PMID: 27773835

4

What Mechanisms Are Responsible for the Reuptake of Levodopa-Derived Dopamine in Parkinsonian Striatum?

Nishijima H, Tomiyama M. Nishijima H, et al. Front Neurosci. 2016 Dec 15;10:575. doi: 10.3389/fnins.2016.00575. eCollection 2016. Front Neurosci. 2016. PMID: 28018168 Free PMC article. Review.

5

Effects of duloxetine on motor and mood symptoms in Parkinson's disease: An open-label clinical experience.

Nishijima H, Ueno T, Kon T, Haga R, Funamizu Y, Arai A, Suzuki C, Nunomura JI, Baba M, Tomiyama M. Nishijima H, et al. J Neurol Sci. 2017 Apr 15;375:186-189. doi: 10.1016/j.jns.2017.01.066. Epub 2017 Jan 25. J Neurol Sci. 2017. PMID: 28320128 Clinical Trial. No abstract available.

6

Spine Enlargement of Pyramidal Tract-Type Neurons in the Motor Cortex of a Rat Model of Levodopa-Induced Dyskinesia.

Ueno T, Nishijima H, Ueno S, Tomiyama M. Ueno T, et al. Among authors: nishijima h. Front Neurosci. 2017 Apr 13;11:206. doi: 10.3389/fnins.2017.00206. eCollection 2017. Front Neurosci. 2017. PMID: 28450828 Free PMC article.

7

Zonisamide Enhances Motor Effects of Levodopa, Not of Apomorphine, in a Rat Model of Parkinson's Disease.

Nishijima H, Miki Y, Ueno S, Tomiyama M. Nishijima H, et al. Parkinsons Dis. 2018 Dec 18;2018:8626783. doi: 10.1155/2018/8626783. eCollection 2018. Parkinsons Dis. 2018. PMID: 30662707 Free PMC article.

8

Assessing the relationship between non-motor symptoms and health-related quality of life in Parkinson's disease: a retrospective observational cohort study.

Ueno T, Kon T, Haga R, Nishijima H, Arai A, Tomiyama M. Ueno T, et al. Among authors: nishijima h. Neurol Sci. 2020 Oct;41(10):2867-2873. doi: 10.1007/s10072-020-04406-5. Epub 2020 Apr 23. Neurol Sci. 2020. PMID: 32328832

9

Effects of Aging on Levo-Dihydroxyphenylalanine- Induced Dyskinesia in a Rat Model of Parkinson's Disease.

Nishijima H, Kimura T, Mori F, Wakabayashi K, Kinoshita I, Nakamura T, Kon T, Suzuki C, Tomiyama M. Nishijima H, et al. Front Aging Neurosci. 2021 May 13;13:650350. doi: 10.3389/fnagi.2021.650350. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34054505 Free PMC article.

10

Cabergoline, a long-acting dopamine agonist, attenuates L-dopa-induced dyskinesia without L-dopa sparing in a rat model of Parkinson's disease.

Nishijima H, Mori F, Kimura T, Miki Y, Kinoshita I, Nakamura T, Kon T, Suzuki C, Wakabayashi K, Tomiyama M. Nishijima H, et al. Neurosci Res. 2022 May;178:93-97. doi: 10.1016/j.neures.2022.02.001. Epub 2022 Feb 9. Neurosci Res. 2022. PMID: 35150767

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

309 results

Search Page